Oracle (NYSE:ORCL) was in focus on Thursday as investment firm Argus raised its earnings estimates and upgraded the IT tech giant after it reported fiscal third-quarter results. Shares were flat in ...

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier ...

AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research Organization (CRO), PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of ...

Oracle Corporation (NYSE:ORCL) ranks among the best rebound stocks to buy right now. On March 13, Argus reduced its price ...

The MarketWatch News Department was not involved in the creation of this content. Oracle's leading safety platform will help Voisin enhance compliance, mitigate risk, and expand global service ...

Argus analyst Joseph Bonner raised the firm’s price target on Oracle (ORCL) to $200 from $176 and keeps a Buy rating on the shares after its Q2 results. The company is in the enviable position of ...

Investing.com - Argus lowered its price target on Oracle Corp. (NYSE:ORCL) to $225 from $384 while maintaining a Buy rating. Analyst Joseph Bonner cited market concerns about whether the company’s ...

Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research ...

Oracle's leading safety platform will help Voisin enhance compliance, mitigate risk, and expand global service offerings for its pharmaceutical clients "As a CRO deeply invested in specialized ...